# Effect of Low-dose Interferon-alfa2a on Peri-operative Immune Suppression

> **NCT04798612** · PHASE2 · UNKNOWN · sponsor: **Zealand University Hospital** · enrollment: 68 (estimated)

## Conditions studied

- Colon Cancer

## Interventions

- **DRUG:** Pegasys
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT04798612
- **Lead sponsor:** Zealand University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08-14
- **Primary completion:** 2025-08-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2023-08-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04798612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04798612, "Effect of Low-dose Interferon-alfa2a on Peri-operative Immune Suppression". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04798612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*